LGND - Ligand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39 revenue of $43.9M beats by $10.35M
2023-05-04 17:01:56 ET
- Ligand Pharmaceuticals press release ( NASDAQ: LGND ): Q1 Non-GAAP EPS of $2.28 beats by $1.39 .
- Revenue of $43.9M (+20.3% Y/Y) beats by $10.35M .
For further details see:
Ligand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39, revenue of $43.9M beats by $10.35M